MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for early MS: Twice-Yearly infusion trial launches
Disease control Recruiting nowThis study tests a drug called Ublituximab (Briumvi) given twice a year to people with early relapsing multiple sclerosis. Researchers want to see if it is safe and how it affects a nerve damage marker in the blood. About 40 adults with mild disability will take part for about on…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a new MS drug help you walk better and avoid falls?
Disease control Recruiting nowThis early-phase study tests whether ublituximab, a drug for relapsing multiple sclerosis, can improve walking function and reduce fall risk. Twenty-five participants will receive the drug for 48 weeks, with walking, disability, and thinking tests before, during, and after treatm…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: EARLY_PHASE1 • Sponsor: Georgia State University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could broccoli compound slow Parkinson's and MS? new trial launches
Disease control Recruiting nowThis study is testing a supplement made from a broccoli compound (bioactivated GRA) in 300 people with Parkinson's disease, relapsing-remitting multiple sclerosis, or certain childhood nerve diseases. Participants will take the supplement daily for 6 months. Researchers will trac…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can imagining movements help MS patients walk and think better?
Symptom relief Recruiting nowThis study tests a new 8-week program that combines motor imagery (mentally practicing movements) with vestibular rehabilitation (exercises for balance and dizziness) in 30 people with relapsing-remitting multiple sclerosis. The goal is to see if this combination improves balance…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 12:27 UTC
-
Vibrating sleeves tested to help MS patients regain arm control
Symptom relief Recruiting nowThis study tests whether a wearable device that gently vibrates arm muscles can improve arm and hand function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS will use the device at home for 4 weeks. Researchers will measure dexterity, coordinati…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can a home balance game boost brain and body in MS?
Symptom relief Recruiting nowThis study tests a home-based balance training program for people with multiple sclerosis (MS). The program combines stepping games, strength, and thinking tasks. Researchers will compare it to a simple stretching routine in 75 adults with MS to see if it improves physical functi…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Blood test could replace gadolinium scans for MS monitoring
Knowledge-focused Recruiting nowThis study is testing whether monthly blood tests for a nerve damage marker (neurofilament light chain) can detect hidden disease activity in people with relapsing-remitting multiple sclerosis (MS) earlier than standard yearly MRI scans. The goal is to reduce the need for gadolin…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Eye scans could reveal hidden clues about MS drug effectiveness
Knowledge-focused Recruiting nowThis study will test whether a special eye scan (OCT) can detect changes in the retina that show how well the MS drug ublituximab is working. Researchers will compare 15 people starting ublituximab with 15 people on other MS treatments. The goal is to find a new, non-invasive way…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Your Phone's selfie camera could be the new MS monitor
Knowledge-focused Recruiting nowThis study looks at whether short selfie videos taken on a phone can accurately measure walking and speech changes in people with multiple sclerosis (MS). About 300 adults with MS will record 5 videos every 3 months for a year and also attend some in-person visits. The goal is to…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Hidden struggle: study probes sexual problems in women with MS
Knowledge-focused Recruiting nowThis study aims to find out how often sexual dysfunction occurs in women with relapsing-remitting multiple sclerosis and how it connects to fatigue, depression, anxiety, overactive bladder, and thinking problems. Researchers will use questionnaires and tests to measure these fact…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Sponsor: Ege University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC